Cost effectiveness of treating asymptomatic HIV infection.
Publication
, Journal Article
Hamilton, JD; Simberkoff, MS; Hartigan, PM
Published in: Ann Intern Med
October 15, 1991
Duke Scholars
Published In
Ann Intern Med
DOI
ISSN
0003-4819
Publication Date
October 15, 1991
Volume
115
Issue
8
Start / End Page
655 / 656
Location
United States
Related Subject Headings
- Zidovudine
- Humans
- HIV Infections
- General & Internal Medicine
- Cost-Benefit Analysis
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hamilton, J. D., Simberkoff, M. S., & Hartigan, P. M. (1991). Cost effectiveness of treating asymptomatic HIV infection. Ann Intern Med, 115(8), 655–656. https://doi.org/10.7326/0003-4819-115-8-655
Hamilton, J. D., M. S. Simberkoff, and P. M. Hartigan. “Cost effectiveness of treating asymptomatic HIV infection.” Ann Intern Med 115, no. 8 (October 15, 1991): 655–56. https://doi.org/10.7326/0003-4819-115-8-655.
Hamilton JD, Simberkoff MS, Hartigan PM. Cost effectiveness of treating asymptomatic HIV infection. Ann Intern Med. 1991 Oct 15;115(8):655–6.
Hamilton, J. D., et al. “Cost effectiveness of treating asymptomatic HIV infection.” Ann Intern Med, vol. 115, no. 8, Oct. 1991, pp. 655–56. Pubmed, doi:10.7326/0003-4819-115-8-655.
Hamilton JD, Simberkoff MS, Hartigan PM. Cost effectiveness of treating asymptomatic HIV infection. Ann Intern Med. 1991 Oct 15;115(8):655–656.
Published In
Ann Intern Med
DOI
ISSN
0003-4819
Publication Date
October 15, 1991
Volume
115
Issue
8
Start / End Page
655 / 656
Location
United States
Related Subject Headings
- Zidovudine
- Humans
- HIV Infections
- General & Internal Medicine
- Cost-Benefit Analysis
- 3202 Clinical sciences
- 11 Medical and Health Sciences